A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics
NCT03019276
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
TQ-B3101
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.